back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-02-03 14:34 Tx date 2026-02-03 |
$INEO
INEO Tech Corp. |
Wambeke, David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,100
-1,110,000 vol $0.01 each |
64,800,000 | |
| Filed 2026-02-03 14:33 Tx date 2026-02-02 |
$INEO
INEO Tech Corp. |
Wambeke, David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-945.00
-90,000 vol $0.0105 each |
65,910,000 | |
| Filed 2026-01-15 18:20 Tx date 2026-01-05 |
$INEO
INEO Tech Corp. |
Wambeke, David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,000
+6,000,000 vol $0.011 each |
66,000,000 | |
| Filed 2026-01-15 18:19 Tx date 2025-12-23 |
$INEO
INEO Tech Corp. |
Wambeke, David
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,000,000 | ||
| Filed 2025-06-03 15:29 Tx date 2025-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
520,000 | |
| Filed 2024-06-18 16:49 Tx date 2024-06-01 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,000 vol |
270,000 | |
| Filed 2023-06-26 12:43 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,100
+10,000 vol $3.91 each |
||
| Filed 2023-06-26 12:41 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$39,100
+10,000 vol $3.91 each |
||
| Filed 2023-06-26 12:41 Tx date 2023-06-23 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$150,003
+38,364 vol $3.91 each |
507,114 | |
| Filed 2023-04-13 14:16 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+140,000 vol |
140,000 | |
| Filed 2023-04-12 19:46 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
468,750 | ||
| Filed 2023-04-12 19:45 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-12 19:41 Tx date 2023-04-10 |
$DMAC
DiaMedica Therapeutics Inc. |
Wambeke, David
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|